DOI QR코드

DOI QR Code

Effects of Natural Honeybee (Apis mellifera ligustica) Venom Treatment on the Humoral Immune Response in Pigs

Beevenom 처리가 돼지의 체내 면역반응에 미치는 효과

  • Published : 2006.12.31

Abstract

This experiment was carried out to investigate effects of honeybee venom treatment on the humoral immune response in pigs. Corresponding author : S. K. Cho, Dept. of Animal Sci. Chung-Buk National University, Kaesin-dong, Cheongju, 361-763, Korea. phone : 043-261-2551. E-mail : deercho@chungbuk.ac.kr To investigate effects of natural honeybee venom on the concentration of immunoglobulin G, A, and M, 20 piglets(LY×D) from 3 sows were allocated into two groups bee venom-treated group(10 piglets) and non-treated control(10 piglets). Natural honeybee venom was treated at 0, 3, 6 days after birth and the acupoints were Hai-men(ST-25), Du-kou(CV-8) and Jiao-chao(GV-1) points at 0, 3 days after birth and the regions of castration and tail amputation point at 6 days. Control group was injected 1㎖ of saline to the same site. Concentrations of IgG, A, and M were measured with immunoturbidimetric method at 0, 3, 7, 14, and 21 days after treatment. To investigate the effect of bee venom on the production of antibodies against hog cholera and atrophic rhinitis vaccines that were used as indicator antigens, 40 piglets(LYxD) from 5 sows were grouped as bee venom-treated group (20 piglets) and control group(20 piglets). Natural honeybee venom was treated at 0, 3days(castration, tail amputation) and 21days after birth. The acupoints were Hai-men(ST-25), Du-kou(CV-8) and Jiao-chao (GV-1) points at 0 day, the regions of castration and tail ampution at 3 days and Jiao-chao(GV-1) and Bai-hui(GV-20) points at 21days after birth(weaning). Control group was injected 1ml of saline to the same site. Atrophic rhinitis vaccine was injected twice at 24 and 44 days after birth and hog cholera vaccine was also injected twice at 44 and 64 days after birth. Antibody titers against Bordetella bronchiseptica and hog cholera virus were measured by using tube agglutination and ELISA tests at 24, 34, 44, 54 and 74 days after birth. Concentrations of IgG of treated group were 339.52, 366.48, 296.52, 242.06 and 219.06mg/dl at 0, 3, 7, 14 and 21 days after birth, respectively. In contrast, concentrations of IgG in control group were respectively 347.10, 334.14, 243.28, 205.18 and 191.58mg/dl during same periods with treated group. Concentrations of IgG at 0 day was not significantly different between the treated group and control group but treated group were significantly increased by 10.28% at 3 days after birth (P<0.02), 21.88% at 7 days after birth(P<0.01), 18.0% at 14 days after birth(P<0.07) and 14.3% at 21 days after birth(P<0.01). Concentrations of IgA and Ig M were not significantly different. Antibody titers against hog cholera virus were significantly increased by 57.0% at 24 days after birth(P<0.03), 74.6% at 34 days after birth (P<0.006), 48.6% at 44 days after birth(P<0.017), 45.0% at 54 days after birth(P<0.16) and 44.4% at 74 days after birth (P<0.006) in bee venom treated group in comparison with control group. Antibody titers against the Bordetella bronchiseptica was significantly increased in Beevenom treated group as 9.1% (P<0.32) at 24days, 39.7% (P<0.002) at 34days, 31.9% (P<0.02) at 44days, 33.4% (P<0.01) at 54days and 57.3% (P<0.007) at 74 days after birth when compared with those of control group pigs. Collecting together, the results in this study showed that immune responses were increased by treatment of natural honeybee venom to pigs. These results suggested that the treatment of bee venom could be used effectively for the increase of productivity in livestock industry.

본 실험은 생봉독 처리가 돼지의 체액성 면역반응에 대한 생봉독의 효과를 조사하기 위하여 실시하였다. 혈중 Immunoglobulin(Ig) G, IgA, IgM의 농도에 미치는 생봉독의 효과를 조사하기 위하여 모돈 3두에서 생산한 자돈 20두(LY ×D)를 생봉독 처리군과 대조군으로 각각 10두씩 배치하였다. 생봉독 처리군은 출생시와 3일령에 교소혈 (GV-1), 해문혈(ST-25) 및 두구혈(CV-8), 6일령에 거세, 단미 창상부위에 생봉 1마리씩 직침 시술하였고, 대조군은 생리식염수 1ml를 동일한 혈위에 주입하였다. 혈중 Ig 농도 측정을 위하여 출생시와 3일, 7일, 14일 및 21일령에 채혈하여 Immunoturbidimetric method로 IgG, IgM, IgA를 측정하였다. 지표항원으로 사용한 돈 콜레라와 위축성비염 백신에 대한 생봉독의 항체 생성효과를 조사하기 위하여 모돈 5두에서 생산된 자돈 40두(LY×D)를 생봉독 처리군과 대조군으로 각각 20두씩 공시하였다. 생봉독 처리군은 출생시에 교소혈(Jiao-Chao, GV-1), 해문혈(Hai-Men, ST-25) 및 두구혈(Du-Kou, CV-8)에, 3일령에 단미 및 거세시술 시 창상부위에 생봉독을 처리하였고, 21일령 이유시에는 교소혈(GV-1)과 백회혈(Bai- Hui, GV-20)에 생봉독을 처리하였다. 지표항원으로 위축성비염 백신은 24일령과 44일령에 접종하였고 돈콜레라 백신은 44일령과 64일령에 각각 접종하였다. 항체가 분석용 혈액은 24, 34, 44, 54 및 74일령에 채혈하여 위축성비염은 시험관응집반응, 돈콜레라는 ELISA법에 의하여 항체가를 조사하였다. IgG 농도는 처리군에서 출생시 339.52, 3일령에 366.48, 7일령에 296.52, 14일령에 242.06, 21일령에는 219.06mg/dl이었고 대조군은 각각 347.10, 333.14, 243.28, 205.18 및 191.58mg/dl 이었다. 처리전(출생시)에는 처리군과 대조군간에 유의차가 없었으나 처리군의 IgG 농도가 대조군에 비하여 3일령 10.3% (P<0.02), 7일령에는 21.9% (P<0.01), 14일령에는 18.0% (P<0.07), 21일령에는 14.3(P<0.07) 더 높게 나타났다. IgA와 IgM의 농도는 전체기간동안 처리군과 대조군간에 유의차가 인정되지 않았다. 돈콜레라 virus에 대한 항체역가는 처리군에서 대조군에 비하여 24일령 때 57.0%(P<0.03), 34일령 때 74.6% (P<0.006), 44일령에 48.6% (P<0.017), 54일령 때 45.0% (P<0.16), 74일령 때 44.4%(P<0.006)가 유의하게 높은 것으로 나타났다. 위축성비염 원인균인 Bordetella bronchiceptica에 대한 항체역가는 처리군이 대조군에 비하여 34일령 때는 39.7%(P<0.002), 44일령 때 31.9% (P<0.02), 54일령 때에 33.4%(P<0.01), 74일령 때에는 57.3%(P<0.007)가 높게 나타나 접종일인 24일령을 제외하고 전체기간에 걸쳐 높은 항체수준을 보였다. 위의 결과를 종합해 볼 때 돼지에 대한 생봉독 처리는 면역기능향상 효과가 있는 것으로 사료된다. 이와 같은 결과를 볼 때 돼지에 대한 생봉독의 처리는 양돈 생산성면에서 생봉독 처리는 돼지의 생존율을 높이고, 증체량이 높았다는 조 등(2005)의 보고를 뒷받침하고 있어 양돈 산업발전에 기여할 것으로 사료된다.

Keywords

References

  1. Artemov, N. M. and Orlov, B. N. 1967. New data to scientifically support the physiological use of bee venom as a medicine. In : Proceeding in the XXI International congress : p.p. 348-353
  2. Barker, S. A. 1966. Separation and isolation of the hyaluronidase and phospholipase components of bee venom and investigation of bee venom human serum interactions. Clin. Chim. Acta. 13:582-596 https://doi.org/10.1016/0009-8981(66)90162-8
  3. Becker, W., Rapp, W., Schenk, H. G. and Storiko, K. 1968. Methden zur quantitativen bestimmung von plasmaproteinen dutch Immunoprilzipitation. Z. Klin. Chem. Biochem. 6:113-122.
  4. Belliveau, J. F. 1982. The comparison of bee venom fraction by their layer isoelective focusing. NAAS. Proceedings 5:34-37
  5. Benjamini, E., Sunshine, G. and Leskowitz, S. 1996. Immunology a Short Course. Wiley-Liss. New York. p.p. 57-92
  6. Bodansky, O. and Lamer, A. L. 1971. Advance in clinical chemistry. Academic press. New York. 14:219-317
  7. Brostoff, I., Scadding, G. H., Male, D. and Roitt, I. M. 1991. Clinical immunology. Gower Medical Publishing. London. p.p. 11-18
  8. Curcio, V., Onlanthen, V., Schneider, C. H., Frutig, K., Blaser, K. and Kalbacher, H. 1997. Moecular parameters in melittin immunogenicity. J. Pept. Sci. 3:267-276 https://doi.org/10.1002/(SICI)1099-1387(199707)3:4<267::AID-PSC106>3.0.CO;2-7
  9. Doery, H. M. 1964. Phospholipase B in snake venoms and bee venom. Biochem. J. 92:599-602 https://doi.org/10.1042/bj0920599
  10. Dunn, J. D. and Killion, J. J. 1988a. Effect of melittin on pituitary adrenal responsiveness to stress. Acta. Endorinol. (Copenh). 119:339-344
  11. Dunn, J. D. and Killion, J. J. 1988b. Melittin- evoked increase in plasma corticosterone levels. Life Sci. 43:335-343 https://doi.org/10.1016/0024-3205(88)90111-7
  12. Gauldie, J., Hanson, J. M., Rumjanek, F. D., Shipolini, R. A. and Vernon, C. A. 1976. The peptide components of bee venom. Eur. J. Biochem. 61:369-376 https://doi.org/10.1111/j.1432-1033.1976.tb10030.x
  13. Gauldie, J., Hanson, J. M., Shipolini, R. A. and Vernon, C. A. 1978. The structures of some peptides from bee venom. Eur, J. Biochem. 83:405-410 https://doi.org/10.1111/j.1432-1033.1978.tb12106.x
  14. Habermann, E. and Reiz, K. G. 1965. On the biochemistry of bee venom peptides, melittin and apamin. Biochem. Z. 343:192-203
  15. Hanson, J. M., Morley, J. and Herrera, C. S. 1974. Anti-inflammatory property of 401(MCD- peptide) a peptide from the venom of the bee, Apis mellifera. Br. J. Pharmacol. 50:383-392 https://doi.org/10.1111/j.1476-5381.1974.tb09613.x
  16. Hoffmann, P., Loleit, M., Mittenbuhler, K., Beck, W., Wiesmuller, K. H., Jung, G. and Bessler, W. G. 1997. Induction of an epitope-specific humoral immune response by lipopeptide hapten conjugates: enhancement of the anti-melittin response by a synthetic T helper (Th)-cell epitope. FEMS. Immunol. Med. Microbial. 17:225-234 https://doi.org/10.1016/S0928-8244(97)00010-2
  17. Jentsch, J. 1969. Further studies on the amino acid sequence of melittin. 3. Hydrolysis with highly purified trypsin. Z. Naturforsch. 24:264-265
  18. Jentsch, J. 1972. Phospholipase A (EC 3. 1. 1. 4) from bee venom. II. At least two phospholipases A in bee venom. Justus Liebigs Ann. Chem. 757:187-192 https://doi.org/10.1002/jlac.19727570120
  19. Johnson, A. M. 1993. A new international reference preparation for proteins in human serum. Arch. Pathol. Lab. Med. 117:29-31
  20. Kim, C. M. H. 1986. Bee venom therapy managing pain and stress. 1:1-5
  21. Kim, C. M. H. 1987. Bee venom therapy for arthritis and neuritis pain. Supp. 4, 262
  22. Light, W. C., Reisman, R. E., Shimizu, M. and Arbesman, C. E. 1977. Clinical application of measurements serum level of bee venom specific IgE and IgG. J. Allergy. Clin. Immunol. 59:247-253 https://doi.org/10.1016/0091-6749(77)90158-0
  23. Lockitch, G., Halstead, A. C., Quigley, G. and MacCallum, C. 1988. Age and sex specific pediatric reference intervals; study design and methods illustrated by measurement of serum proteins with the behring LN nephelometer. Clin Chem. 34: 1618-1621
  24. Lowy, P. H. 1971. Polypeptides minimine and melittin from bee venom : effects on drosophila. Arch. Biochem. Biophys. 145:338-343 https://doi.org/10.1016/0003-9861(71)90044-0
  25. Nelson, D. A. 1963. The kenom of the honey bee (Apis mllifera) free amino acids and peptides. Canad. J. Biochem. 46:1221-1226 https://doi.org/10.1139/v68-207
  26. O'Connor, R. and Peck, M. L. 1978. Venoms of the apidae. In Bettin S, Handbook of Experimental pharmacology, Springer-Verlag. Berlin. 48:chaper 21
  27. Owen, M. D. 1971. Chemical components in the venom of Ropalidia Revolutiomalis and Polistes Humilis (Hymenoptena, Vespidae). Toxicon. 17: 519-523 https://doi.org/10.1016/0041-0101(79)90286-1
  28. Owen, M. D. 1974. A quantitative and temporal study of histamine and histidine in honey bee (Apis mellifera L.) venom. Can J. Zool. 52:387-392 https://doi.org/10.1139/z74-046
  29. Owen, M. D. and Bridages, A. R. 1982. catecholamines in Honeybee (Apis mellifera L.) and various vespid (Hymen-optera) venoms. Toxicon. 20:1075 https://doi.org/10.1016/0041-0101(82)90110-6
  30. Peck, M. L., Oconnor, R., Johnson, T. J., lsabell, A. F., Martell, A. E., McLendon, G., Neff, R. D. and Wright, D. A. 1978. Radioprotective potential and chelating properties of glycylhi-samine and analog of histamine terminal peptides found in bee venom. Toxicon. 16:690-694 https://doi.org/10.1016/0041-0101(78)90199-X
  31. Rudenko, S. V. and Nipot, E. E. 1996. Modulation of melittin-induced hemolysis of erythrecytes. Biokhimiia. 61:2116-2124
  32. SAS. 1990. SAS procedures Guide for personal computers, Version 6 Edition. SAS institute Inc.
  33. Schumann, G. and Dati, F. 1995. Vorlaufige Referenz-bereiche fur 14 protein im serum (fur erwachsene) nach standardisierung immunchemischer methoden unter bezug auf das internationale referenzmaterial CRM 470. Lab Med. 19:401-403
  34. Shkenderov, S. H. 1973. Protese inhibitor in bee venom. Identification partial purication and some properties. FEBS Lett. 33:343-347 https://doi.org/10.1016/0014-5793(73)80226-1
  35. Shkenderov, S. H. 1982. Adolapin-a newly analgetic and antiflammatory polipeptide from bee venom. Toxicon. 20:317-321 https://doi.org/10.1016/0041-0101(82)90234-3
  36. Shkenderov, S. H. and Todarv, S. 1979. Effect of bee venom and its low and high molecular fraction on embryogenesis in rats. Eksp. Med. Mor. for. 18:160-165
  37. Steiner, H., Hultmark, D., Engstrom, A., Bennich, H. and Boman, H. G. 1981. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature. 292:246-248 https://doi.org/10.1038/292246a0
  38. Vick, J. A., Brooks, B. and Shipman, W. 1972. Therapeutic applications of bee venom and Its components in the dog. American bee journal. 11 :414-416
  39. 李長卿. 苑文學. 1989. 中國獸醫鍼灸圖譜. 甘肅科學技術出版社. 甘肅省. p.p. 115-123
  40. 竹中良二, 高橋貢. 1984. 中國獸醫鍼灸學. 文永堂. 東京. p.p. 156-183, 262
  41. 강성수, 최석화, 조성구. 1999. 관절염 유발 랫드에 대한 생봉독의 치료효과. 한국임상수의학회지 16:155-162
  42. 김문호. 1992. 봉독요법과 봉침요법. 한국교육기획. 서울. p.p. 20-103
  43. 김병한, 탁동섭, 송재영, 최강석, 안동준, 현방훈, 안수환. 1994. 돼지콜레라 항체검사법 개량연구. 수의과학 시험연구보고서. 농촌진흥청. p.p. 185- 190
  44. 조성구, 권영방, 최석화. 1998. 생봉독 주입에 의한 가축의 다발성 질환 치료법 개발. 농림부 농업기술개발센터. p.p. 22-25
  45. 조성구, 김경수, 이석천. 2005. 생봉독 처리가 돼지의 생산성에 미치는 효과. 한국동물자원과학회지. 47(2):293-304
  46. 최석화, 강성수. 1998. 단미창상의 생봉독 요법. 한국임상수의학회지. 15:247-250